Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous perpheral blood progenitor cell transplantation: a retrospective analysis

Abstract

A pilot study analyses an effect of selected demographic, psychosocial and health aspects on quality of life (QoL) in multiple myeloma survivors treated with high-dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation (PBPCT).